Slack & Davis Hires Litigator John R. Davis

Slack & Davis L.L.P, a national aviation, personal injury and pharmaceutical law firm, has added Litigator John R. Davis to the firm’s Austin office. Davis focuses on complex litigation with an emphasis in pharmaceutical, medical device, class action, and environmental cases.

“John is a very talented attorney who brings an impressive background in complex litigation,” said Michael L. Slack, Managing Partner of Slack & Davis. “The number of dangerous drugs and defective medical devices on the market is ever-growing, and John is a great fit to lead our efforts against the pharmaceutical and device companies that manufacture them.”

Davis was recently the point attorney on a high profile pharmaceutical antitrust class action involving delayed generic competition allegations regarding a popular ADHD medicine. Barba et al. v. Shire US, Inc., et al. (S.D. Fla.). Court approval of a settlement is pending. He further created the case idea, drafted a highly detailed 400-page complaint asserting over 50 causes of action, and helped secure client representation in Medical Mutual of Ohio v. AbbVie Inc., et al., a RICO class action currently pending in the In re: Testosterone Replacement Therapy MDL. Davis also represented the State of Louisiana in litigating and settling numerous Medicaid fraud cases filed against pharmaceutical manufacturers for fraudulent promotion and marking of prescription drugs. Davis was also part of the trial team that secured a landmark $225 million post-trial settlement on behalf of the State of New Jersey in environmental damages claims against ExxonMobil.

Prior to entering private practice, Mr. Davis served as a law clerk in federal district court for two years.

Davis obtained his Juris Doctor from Boston College Law School and graduated with a Bachelor of Arts from Trinity University. He was a recipient of Trinity University’s Trustees’ Scholarship and a member of the National French Honors Society.


Slack & Davis Hires Litigator John R. Davis — 1 Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

HTML tags are not allowed.

853,986 Spambots Blocked by Simple Comments